Iranian Red Crescent Medical Journal

Published by: Kowsar

The Clinical and Pathological Analysis of Ovarian Borderline Serous Papillary Epithelioma: A Report of Six Cases

Manzhen Zuo 1 , * , Hongying Du 2 , Aihua Chen 1 , Yan Wang 1 , Dandan Quan 1 , Yaling Tao 1 and Huamei Song 1
Authors Information
1 Department of Gynecology and Obstetrics, People’s Hospital of Three Gorges University / The First People’s Hospital of Yichang, Yichang, Hubei, China
2 Department of Gynecology and Obstetrics, People’s Hospital of Dangyang, Dangyang, Hubei, China
Article information
  • Iranian Red Crescent Medical Journal: May 2017, 19 (5); e40180
  • Published Online: October 19, 2016
  • Article Type: Case Report
  • Received: June 19, 2016
  • Revised: August 20, 2016
  • Accepted: September 9, 2016
  • DOI: 10.5812/ircmj.40180

To Cite: Zuo M, Du H, Chen A, Wang Y, Quan D, et al. The Clinical and Pathological Analysis of Ovarian Borderline Serous Papillary Epithelioma: A Report of Six Cases, Iran Red Crescent Med J. 2017 ; 19(5):e40180. doi: 10.5812/ircmj.40180.

Copyright © 2016, Iranian Red Crescent Medical Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Introduction
2. Case Presentation
3. Discussion
  • 1. Auer K, Bachmayr-Heyda A, Aust S, Sukhbaatar N, Reiner AT, Grimm C, et al. Peritoneal tumor spread in serous ovarian cancer-epithelial mesenchymal status and outcome. Oncotarget. 2015; 6(19): 17261-75[DOI][PubMed]
  • 2. Ghaemi N, Bagheri S, Elmi S, Mohammadzade Rezaee S, Elmi S, Erfani Sayyar R. Delayed Diagnosis of Hypothyroidism in Children: Report of 3 Cases. Iran Red Crescent Med J. 2015; 17(11): 20306[DOI][PubMed]
  • 3. Imamura H, Ohishi Y, Aman M, Shida K, Shinozaki T, Yasutake N, et al. Ovarian high-grade serous carcinoma with a noninvasive growth pattern simulating a serous borderline tumor. Hum Pathol. 2015; 46(10): 1455-63[DOI][PubMed]
  • 4. Boyd C, McCluggage WG. Low-grade ovarian serous neoplasms (low-grade serous carcinoma and serous borderline tumor) associated with high-grade serous carcinoma or undifferentiated carcinoma: report of a series of cases of an unusual phenomenon. Am J Surg Pathol. 2012; 36(3): 368-75[DOI][PubMed]
  • 5. Hale D, Senem DA, Ovgu A, Hakan E, Sennur I, Zerrin C, et al. Serous Ovarian Carcinoma Recurring as Malignant Mixed Mullerian Tumor. Case Rep Obstet Gynecol. 2015; 2015: 612824[DOI][PubMed]
  • 6. Cheng JC, Auersperg N, Leung PC. TGF-beta induces serous borderline ovarian tumor cell invasion by activating EMT but triggers apoptosis in low-grade serous ovarian carcinoma cells. PLoS One. 2012; 7(8): 42436[DOI][PubMed]
  • 7. Shih Ie M. Ovarian serous low malignant potential (borderline) tumor--does "micropapillary" matter? Gynecol Oncol. 2010; 117(1): 1-3[DOI][PubMed]
  • 8. Homaei Shandiz F, Kadkhodayan S, Hsanzade Mofrad M, Yousefi Roodsari Z, Sharifi Sistani N, Nabizadeh Marvast M, et al. Prolonged survival of a patient with pelvic recurrence of ovarian malignant mixed mullerian tumor after chemoradiotherapy. Iran Red Crescent Med J. 2014; 16(9): 14919[DOI][PubMed]
  • 9. Ludovisi M, Foo X, Mainenti S, Testa AC, Arora R, Jurkovic D. Ultrasound diagnosis of serous surface papillary borderline ovarian tumor: A case series with a review of the literature. J Clin Ultrasound. 2015; 43(9): 573-7[DOI][PubMed]
  • 10. Njim L, Moussa A, Saidani Z, Touil N, Mlik L, Belghith M, et al. Bilateral ovarian serous borderline tumor with a giant non-invasive peritoneal implant in a four-year-old girl. J Pediatr Adolesc Gynecol. 2010; 23(1): 1-4[DOI][PubMed]
  • 11. Tepeoglu M, Ozen O, Ayhan A. Ovarian serous borderline tumor detected by conventional papanicolaou smear: a case report. Acta Cytol. 2013; 57(1): 96-9[DOI][PubMed]
  • 12. Pourganji M, Hosseini M, Soukhtanloo M, Zabihi H, Hadjzadeh MA. Protective role of endogenous ovarian hormones against learning and memory impairments and brain tissues oxidative damage induced by lipopolysaccharide. Iran Red Crescent Med J. 2014; 16(3): 13954[DOI][PubMed]
  • 13. Ohman AW, Hasan N, Dinulescu DM. Advances in tumor screening, imaging, and avatar technologies for high-grade serous ovarian cancer. Front Oncol. 2014; 4: 322[DOI][PubMed]
  • 14. Rekhi B, Vinarkar S, Shylasree ST. Bilateral ovarian serous cystadenofibromas coexisting with an incidental unilateral Brenner tumor and Walthard cell rests in bilateral Fallopian tubes: an unusual case with diagnostic implications and histogenesis. Indian J Pathol Microbiol. 2014; 57(2): 347-8[DOI][PubMed]
  • 15. Shimamoto A, Isomoto I, Segawa K, Matsumoto A, Abe K, Uetani M. The MRI findings in a case of ovarian mucinous borderline tumor mimicking a serous surface borderline tumor. Jpn J Radiol. 2014; 32(9): 552-5[DOI][PubMed]
  • 16. Zhang C, Wang YE, Zhang P, Liu F, Sung CJ, Steinhoff MM, et al. Progressive loss of selenium-binding protein 1 expression correlates with increasing epithelial proliferation and papillary complexity in ovarian serous borderline tumor and low-grade serous carcinoma. Hum Pathol. 2010; 41(2): 255-61[DOI][PubMed]
  • 17. Ureyen I, Karalok A, Tasci T, Turkmen O, Boran N, Tulunay G, et al. The Factors Predicting Recurrence in Patients With Serous Borderline Ovarian Tumor. Int J Gynecol Cancer. 2016; 26(1): 66-72[DOI][PubMed]
  • 18. Akman L, Akdemir A, Terek MC, Zekioglu O. Ovarian malignant Brenner tumor in patients over 65 years of age. Kaohsiung J Med Sci. 2014; 30(3): 159-60[DOI][PubMed]
  • 19. Cho HJ, Suh DS, Moon SH, Song YJ, Yoon MS, Park DY, et al. Silibinin inhibits tumor growth through downregulation of extracellular signal-regulated kinase and Akt in vitro and in vivo in human ovarian cancer cells. J Agric Food Chem. 2013; 61(17): 4089-96[DOI][PubMed]
  • 20. Grabowska-Derlatka L, Derlatka P, Palczewski P, Danska-Bidzinska A, Pacho R. Differentiation of ovarian cancers from borderline ovarian tumors on the basis of evaluation of tumor vascularity in multi-row detector computed tomography--comparison with histopathology. Int J Gynecol Cancer. 2013; 23(9): 1597-602[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments